CEO Kevin Richardson of SANUWAVE Health, Inc. (OTCQB: SNWV), returns to give details on taking to market their FDA cleared dermaPace technology to treat diabetic foot ulcers.

OTCQB: SNWV # FDA Clearance # Brazlian market # PACE Science # wound healing # Diabetic Foot Ulcers # Orthopedics # acoustic shockwave therapy # Arteriogenesis # Brazil # Diabetic Foot Ulcers # International Distributors # Orthopedics # PACE Science # Penny Stocks # wound healing